EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids

J Fernandes, D Liao, A Dasgupta, M N Tsao, E A Barnes

Clinical Oncology · 2024

DOI: 10.1016/j.clon.2024.03.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2024. Verfasst von J Fernandes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Keloid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Many individuals suffer from keloids that are refractory to standard treatment modalities, including surgical excision alone. Radiation therapy can be used to reduce the risk of recurrent keloids post-operatively, as well as be used as primary treatment for keloids not amenable to surgical resection. The purpose of this study was to review our institutional experience of radiation therapy for keloid management. MATERIALS AND METHODS: A retrospective review of patients treated with radiation therapy for keloids between 2014 and 2020 at our institution was performed. RESULTS: A total of 70 keloids in 41 patients were treated. For the 55 keloids treated with post-operative radiation therapy (16Gy delivered in 2 fractions), 82.5% (33/40) of evaluable lesions did not recur. Among the 15 keloids treated with definitive radiation therapy (24Gy delivered in 3 fractions), 78.6% (11/14) of evaluable keloids showed complete flattening, and 14.3% (2/14) had partial flattening. Both acute and late toxicities were mild, with only a single instance of grade 3 toxicity (dermatitis). CONCLUSION: Our study confirms that radiation therapy has a role in reducing the risk of keloid recurrence post-operatively, and plays an important role in the definitive management of unresectable keloids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeloidHumansRetrospective StudiesFemaleMaleMiddle AgedAdultAgedRadiotherapy, AdjuvantYoung AdultAdolescent

Stichwörter der Autor:innen

Keloidradiation therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: Toni.Barnes@sunnybrook.ca.

Zitieren

APA

Fernandes, J., Liao, D., Dasgupta, A., Tsao, M. N., & Barnes, E. A. (2024). A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids. Clinical Oncology. https://doi.org/10.1016/j.clon.2024.03.018

Vancouver

Fernandes J, Liao D, Dasgupta A, Tsao MN, Barnes EA. A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids. Clinical Oncology. 2024. doi:10.1016/j.clon.2024.03.018

BibTeX
@article{Fernandes2024,
  author = {Fernandes, J and Liao, D and Dasgupta, A and Tsao, M N and Barnes, E A},
  title = {A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids},
  journal = {Clinical Oncology},
  year = {2024},
  doi = {10.1016/j.clon.2024.03.018}
}
Kostenlos starten →